Skip to main content

Table 5 [Baseline] demographic and clinical characteristics between two treatment groups of clomiphene-metformin combination

From: Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism

Item Group I (Clomiphene and Metformin) Group II (Clomiphene alone) P-value
N 37 36  
Age (years) 28.86 ± 0.53 27.36 ± 0.65 0.08
BMI (Kg/m2) 25.13 ± 0.36 25.08 ± 0.30 0.91
Duration of infertility (years) 2.17 ± 0.2277 1.911 ± 0.2116 0.42
Spontaneous menstrual cycle interval (months) 3.42 ± 0.38 2.66 ± 0.34 0.14
Menstrual flow length (days) 6.62 ± 0.55 6.53 ± 0.53 0.90
HbA1c (%) 5.79 ± 0.04 5.74 ± 0.05 0.53
HOMA-IR 3.30(2.56, 4.49) 3.42(2 .78, 3.91) 0.72